CDTX vs MKTX · rev $1.3M vs P/E 13, rev $817.1M
Cidara Therapeutics Inc (CDTX) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
CDTX currently screens at market cap $6.96B. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the CDTX and MKTX stock pages for the full models.
Not investment advice.